nbcnews1

Click link below picture

.

Truvada, the other “little blue pill,” is taken daily to prevent HIV and has been touted as a miracle drug responsible for lowering HIV rates across the United States. But soon, the daily pill may be overshadowed by an even simpler method—a single flu shot-like injection at the doctor’s office, once every two months.

The National Institutes of Health (NIH) announced last week that it was entering the first-ever global clinical trial of an injectable HIV-prevention drug called cabotegravir. The trial is taking place in eight countries across three world regions—the Americas, Africa and Asia—and researchers are enrolling 4,500 gay and bisexual men along with transgender women, pulling from groups with the highest rates of new infections.

.

Image: Colorized electron microscope image of the HIV virus.HIV, the virus that causes AIDS BSIP/UIG Via Getty Images

.

.

Click link below for article:

.

__________________________________________

http://www.nbcnews.com/feature/nbc-out/single-shot-doctor-s-office-may-be-future-hiv-prevention-n700916

Advertisements